-
Je něco špatně v tomto záznamu ?
JuSpace: A tool for spatial correlation analyses of magnetic resonance imaging data with nuclear imaging derived neurotransmitter maps
J. Dukart, S. Holiga, M. Rullmann, R. Lanzenberger, PCT. Hawkins, MA. Mehta, S. Hesse, H. Barthel, O. Sabri, R. Jech, SB. Eickhoff
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2020
PubMed Central
od 1998
ProQuest Central
od 2021-08-01
Medline Complete (EBSCOhost)
od 2012-07-01
Health & Medicine (ProQuest)
od 2021-08-01
Wiley-Blackwell Open Access Titles
od 2020
ROAD: Directory of Open Access Scholarly Resources
od 1993
PubMed
33079453
DOI
10.1002/hbm.25244
Knihovny.cz E-zdroje
- MeSH
- jednofotonová emisní výpočetní tomografie * MeSH
- lidé MeSH
- magnetická rezonanční tomografie * MeSH
- mozkový krevní oběh účinky léků MeSH
- nervový přenos * fyziologie MeSH
- neurotransmiterové látky farmakologie MeSH
- neurozobrazování metody MeSH
- Parkinsonova nemoc diagnostické zobrazování metabolismus MeSH
- pozitronová emisní tomografie * MeSH
- receptory neurotransmiterů * účinky léků MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Recent studies have shown that drug-induced spatial alteration patterns in resting state functional activity as measured using magnetic resonance imaging (rsfMRI) are associated with the distribution of specific receptor systems targeted by respective compounds. Based on this approach, we introduce a toolbox (JuSpace) allowing for cross-modal correlation of MRI-based measures with nuclear imaging derived estimates covering various neurotransmitter systems including dopaminergic, serotonergic, noradrenergic, and GABAergic (gamma-aminobutric acid) neurotransmission. We apply JuSpace to two datasets covering Parkinson's disease patients (PD) and risperidone-induced changes in rsfMRI and cerebral blood flow (CBF). Consistently with the predominant neurodegeneration of dopaminergic and serotonergic system in PD, we find significant spatial associations between rsfMRI activity alterations in PD and dopaminergic (D2) and serotonergic systems (5-HT1b). Risperidone induced CBF alterations were correlated with its main targets in serotonergic and dopaminergic systems. JuSpace provides a biologically meaningful framework for linking neuroimaging to underlying neurotransmitter information.
Department of Nuclear Medicine University Hospital of Leipzig Leipzig Germany
Department of Psychiatry and Psychotherapy Medical University of Vienna Vienna Austria
Institute of Neuroscience and Medicine Brain and Behaviour Research Centre Jülich Jülich Germany
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22004614
- 003
- CZ-PrNML
- 005
- 20220127145119.0
- 007
- ta
- 008
- 220113s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/hbm.25244 $2 doi
- 035 __
- $a (PubMed)33079453
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Dukart, Juergen $u Institute of Neuroscience and Medicine, Brain & Behaviour (INM-7), Research Centre Jülich, Jülich, Germany $u Institute of Systems Neuroscience, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
- 245 10
- $a JuSpace: A tool for spatial correlation analyses of magnetic resonance imaging data with nuclear imaging derived neurotransmitter maps / $c J. Dukart, S. Holiga, M. Rullmann, R. Lanzenberger, PCT. Hawkins, MA. Mehta, S. Hesse, H. Barthel, O. Sabri, R. Jech, SB. Eickhoff
- 520 9_
- $a Recent studies have shown that drug-induced spatial alteration patterns in resting state functional activity as measured using magnetic resonance imaging (rsfMRI) are associated with the distribution of specific receptor systems targeted by respective compounds. Based on this approach, we introduce a toolbox (JuSpace) allowing for cross-modal correlation of MRI-based measures with nuclear imaging derived estimates covering various neurotransmitter systems including dopaminergic, serotonergic, noradrenergic, and GABAergic (gamma-aminobutric acid) neurotransmission. We apply JuSpace to two datasets covering Parkinson's disease patients (PD) and risperidone-induced changes in rsfMRI and cerebral blood flow (CBF). Consistently with the predominant neurodegeneration of dopaminergic and serotonergic system in PD, we find significant spatial associations between rsfMRI activity alterations in PD and dopaminergic (D2) and serotonergic systems (5-HT1b). Risperidone induced CBF alterations were correlated with its main targets in serotonergic and dopaminergic systems. JuSpace provides a biologically meaningful framework for linking neuroimaging to underlying neurotransmitter information.
- 650 _2
- $a mozkový krevní oběh $x účinky léků $7 D002560
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a magnetická rezonanční tomografie $7 D008279
- 650 _2
- $a neurozobrazování $x metody $7 D059906
- 650 _2
- $a neurotransmiterové látky $x farmakologie $7 D018377
- 650 _2
- $a Parkinsonova nemoc $x diagnostické zobrazování $x metabolismus $7 D010300
- 650 12
- $a pozitronová emisní tomografie $7 D049268
- 650 12
- $a receptory neurotransmiterů $x účinky léků $7 D017981
- 650 12
- $a nervový přenos $x fyziologie $7 D009435
- 650 12
- $a jednofotonová emisní výpočetní tomografie $7 D015899
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Holiga, Stefan $u Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland
- 700 1_
- $a Rullmann, Michael $u Department of Nuclear Medicine, University Hospital of Leipzig, Leipzig, Germany
- 700 1_
- $a Lanzenberger, Rupert $u Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Hawkins, Peter C T $u Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK
- 700 1_
- $a Mehta, Mitul A $u Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK
- 700 1_
- $a Hesse, Swen $u Department of Nuclear Medicine, University Hospital of Leipzig, Leipzig, Germany
- 700 1_
- $a Barthel, Henryk $u Department of Nuclear Medicine, University Hospital of Leipzig, Leipzig, Germany
- 700 1_
- $a Sabri, Osama $u Department of Nuclear Medicine, University Hospital of Leipzig, Leipzig, Germany
- 700 1_
- $a Jech, Robert $u Department of Neurology and Center of Clinical Neuroscience, Charles University, 1st Faculty of Medicine and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Eickhoff, Simon B $u Institute of Neuroscience and Medicine, Brain & Behaviour (INM-7), Research Centre Jülich, Jülich, Germany $u Institute of Systems Neuroscience, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
- 773 0_
- $w MED00002066 $t Human brain mapping $x 1097-0193 $g Roč. 42, č. 3 (2021), s. 555-566
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33079453 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127145116 $b ABA008
- 999 __
- $a ok $b bmc $g 1751928 $s 1155763
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 42 $c 3 $d 555-566 $e 20201020 $i 1097-0193 $m Human brain mapping $n Hum Brain Mapp $x MED00002066
- LZP __
- $a Pubmed-20220113